Home
About
Overview
Sharing Data
ORCID
Help
History (0)
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Results (26)
More Search Options
Match
Type
Why
Infectious complications of car T-cell therapy: A longitudinal risk model.
Academic Article
Why?
Author Correction: Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy.
Academic Article
Why?
Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy.
Academic Article
Why?
Bloodless chimeric antigen receptor (CAR) T-cell therapy in Jehovah's Witnesses.
Academic Article
Why?
Refining patient selection for CAR T-cell therapy in aggressive large B-cell lymphoma.
Academic Article
Why?
Advances in CAR T-Cell Therapy for Aggressive B-NHL.
Academic Article
Why?
CardioMEMS-Guided CAR T Cell Therapy for Lymphoma in a Patient With Anthracycline-Induced Cardiomyopathy.
Academic Article
Why?
Current Status of CAR T Cell Therapy for Leukemias.
Academic Article
Why?
Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapy.
Academic Article
Why?
Optimization of Metabolic Tumor Volume as a Prognostic Marker in CAR T-Cell Therapy for Aggressive Large B-cell NHL.
Academic Article
Why?
Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T-cell Therapy.
Academic Article
Why?
Biomarkers and cardiovascular outcomes in chimeric antigen receptor T-cell therapy recipients.
Academic Article
Why?
Ventricular fibrillation following autologous intramyocardial cell therapy for inherited cardiomyopathy.
Academic Article
Why?
Ciltacabtagene Autoleucel, an Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-Up.
Academic Article
Why?
Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study.
Academic Article
Why?
Per Page
15
25
50
100
Page
of 2
Next
Prev
Search Criteria
CAR
T
cell therapy
Filter by Type
All
(91)
People
(65)
Research
(26)
_
Click "Why?" to see why an item matched the search.